Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|August 25, 2001
Effectiveness of statins in acute coronary syndromesJ M Foody, S E Nissen
Atherosclerosis|February 13, 2001
Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysisJ M Foody, J A Milberg, G L Pearce, et al.
Annals of Internal Medicine|April 1, 2000
Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohortC R Cole, J M Foody, E H Blackstone, et al.
JAMA|March 10, 1999
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for StentingS R Steinhubl, W A Tan, J M Foody, et al.
The American Journal of Cardiology|March 16, 2001
A propensity analysis of cigarette smoking and mortality with consideration of the effects of alcoholJ M Foody, C R Cole, E H Blackstone, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and womenJ M Foody, J A Milberg, K Robinson, et al.
Journal of Cardiopulmonary Rehabilitation|June 22, 2000
Cardiac rehabilitation participation patterns in a large, tertiary care center: evidence for selection biasG G Blackburn, J M Foody, D L Sprecher, et al.
Circulation|November 18, 2000
HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from The Cleveland Clinic FoundationJ M Foody, F D Ferdinand, G L Pearce, et al.
Neurology|July 28, 2004
Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of strokeS I Sokol, E L Portnay, J P Curtis, et al.
Journal of the American College of Cardiology|August 10, 2000
Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for StentL Cho, E J Topol, C Balog, et al.
Pageof 2